Michael J. Whalen

726 total citations · 1 hit paper
54 papers, 447 citations indexed

About

Michael J. Whalen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Michael J. Whalen has authored 54 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pulmonary and Respiratory Medicine, 28 papers in Surgery and 10 papers in Oncology. Recurrent topics in Michael J. Whalen's work include Bladder and Urothelial Cancer Treatments (23 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Urinary and Genital Oncology Studies (14 papers). Michael J. Whalen is often cited by papers focused on Bladder and Urothelial Cancer Treatments (23 papers), Prostate Cancer Diagnosis and Treatment (14 papers) and Urinary and Genital Oncology Studies (14 papers). Michael J. Whalen collaborates with scholars based in United States and United Kingdom. Michael J. Whalen's co-authors include Joseph A. Carcillo, Timothy M. Carlos, Patrick M. Kochanek, James M. McKiernan, Stephen R. Wisniewski, Lesley Doughty, Ketan K. Badani, David J. Paulucci, Gina M. Badalato and Max Kates and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Michael J. Whalen

45 papers receiving 438 citations

Hit Papers

What is hemoglobin, albumin, lymphocyte, platelet (HALP) ... 2023 2026 2024 2025 2023 25 50 75
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP’s prognostic ability in different cancer types
    2023 79 citations Michael J. Whalen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael J. Whalen United States 11 174 126 89 78 72 54 447
Christine Sam Austria 11 109 0.6× 167 1.3× 95 1.1× 99 1.3× 60 0.8× 35 501
Barton Kenney United States 15 80 0.5× 192 1.5× 76 0.9× 135 1.7× 117 1.6× 33 571
Carlo Ronsini Italy 20 52 0.3× 299 2.4× 105 1.2× 78 1.0× 96 1.3× 77 864
Maria Bianchi Italy 14 99 0.6× 78 0.6× 88 1.0× 33 0.4× 44 0.6× 54 553
Johanna Mäenpää Finland 17 77 0.4× 196 1.6× 74 0.8× 85 1.1× 163 2.3× 46 1.0k
Shelley R. Marder United States 10 231 1.3× 381 3.0× 81 0.9× 33 0.4× 57 0.8× 14 712
Burak Zeybek Türkiye 17 50 0.3× 246 2.0× 64 0.7× 109 1.4× 136 1.9× 64 764
Saveria Spadola Italy 16 90 0.5× 131 1.0× 64 0.7× 92 1.2× 111 1.5× 45 803
Manuel Post Germany 11 154 0.9× 171 1.4× 135 1.5× 41 0.5× 80 1.1× 21 652
Daigo Ochiai Japan 14 88 0.5× 141 1.1× 81 0.9× 42 0.5× 82 1.1× 58 576

Countries citing papers authored by Michael J. Whalen

Since Specialization
Citations

This map shows the geographic impact of Michael J. Whalen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Whalen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Whalen more than expected).

Fields of papers citing papers by Michael J. Whalen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Whalen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Whalen. The network helps show where Michael J. Whalen may publish in the future.

Co-authorship network of co-authors of Michael J. Whalen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Whalen. A scholar is included among the top collaborators of Michael J. Whalen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Whalen. Michael J. Whalen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Vincent, et al.. (2024). Utilization of neoadjuvant chemotherapy (NAC) and pathologic outcomes in upper tract urothelial carcinoma (UTUC).. Journal of Clinical Oncology. 42(16_suppl). e16620–e16620.
3.
Xu, Vincent, et al.. (2024). Metastatic Tropism in Urothelial Carcinoma With Variant Histology: A Comprehensive NCDB Analysis. Clinical Genitourinary Cancer. 22(5). 102179–102179. 1 indexed citations
4.
González, Diego, et al.. (2024). The Evolving Molecular Landscape and Actionable Alterations in Urologic Cancers. Current Oncology. 31(11). 6909–6937. 2 indexed citations
5.
Whalen, Michael J., et al.. (2024). The Role of Whole-Gland and Focal Cryotherapy in Recurrent Prostate Cancer. Cancers. 16(18). 3225–3225. 1 indexed citations
6.
Whalen, Michael J., et al.. (2024). Definitive Local Treatment for Metastatic Prostate Cancer: A National Cancer Database Analysis. Medical Research Archives. 12(8).
7.
Xu, Vincent, et al.. (2024). Efficacy of cytoreductive radical cystectomy in metastatic urothelial bladder cancer based on site and number of metastases. Urologic Oncology Seminars and Original Investigations. 42(5). 162.e11–162.e23.
8.
Xu, Vincent, et al.. (2024). Analysis of Neoadjuvant Chemotherapy Utilization, Pathologic Response, and Overall Survival in Upper Tract Urothelial Carcinoma. Clinical Genitourinary Cancer. 22(6). 102224–102224. 1 indexed citations
9.
Simmens, Samuel J., et al.. (2024). Delaying Surgery in Favorable-Risk Prostate Cancer Patients: An NCDB Analysis of Oncologic Outcomes. Clinical Genitourinary Cancer. 22(3). 102092–102092.
10.
11.
Wynne, Michael K., et al.. (2023). Machine Learning Algorithm Accuracy Using Single- versus Multi-Institutional Image Data in the Classification of Prostate MRI Lesions. Applied Sciences. 13(2). 1088–1088. 7 indexed citations
12.
13.
14.
Wynne, Michael K., et al.. (2023). Patient Demand for Urologists in the United States: A Google Trends Analysis. Urology Practice. 10(2). 155–160.
15.
Whalen, Michael J., et al.. (2022). Current laser therapy options for endoscopic treatment of upper tract urothelial carcinoma. Current Urology. 17(1). 62–67. 1 indexed citations
16.
Rezaei, Katayoon, et al.. (2021). Use of the T-1470 LiteTouch™ Laser in the En Bloc Resection of an Upper Tract Urothelial Cancer. SHILAP Revista de lepidopterología. 2021. 1–4. 6 indexed citations
17.
Paulucci, David J., Michael J. Whalen, & Ketan K. Badani. (2015). Analysis of the Transperitoneal Approach to Robot-Assisted Laparoscopic Partial Nephrectomy for the Treatment of Anterior and Posterior Renal Masses. Journal of Laparoendoscopic & Advanced Surgical Techniques. 25(11). 880–885. 7 indexed citations
18.
Whalen, Michael J., Matthew Danzig, Jamie S. Pak, et al.. (2015). Utilization and Perioperative Outcomes of Partial Cystectomy for Urothelial Carcinoma of the Bladder: Lessons from the ACS NSQIP Database. Urology Practice. 2(3). 109–114. 3 indexed citations
19.
Whalen, Michael J., Edan Shapiro, Michael B. Rothberg, et al.. (2015). Close surgical margins after radical prostatectomy mimic biochemical recurrence rates of positive margins. Urologic Oncology Seminars and Original Investigations. 33(11). 494.e9–494.e14. 7 indexed citations
20.
Lewiss, Resa E., et al.. (2014). Fournier’s Gangrene. Case report. Medical Ultrasonography. 16(3). 262–3. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christine Sam Breakdown of academic impact, for papers by Barton Kenney Breakdown of academic impact, for papers by Carlo Ronsini Breakdown of academic impact, for papers by Maria Bianchi Breakdown of academic impact, for papers by Johanna Mäenpää Breakdown of academic impact, for papers by Shelley R. Marder Breakdown of academic impact, for papers by Burak Zeybek Breakdown of academic impact, for papers by Saveria Spadola Breakdown of academic impact, for papers by Manuel Post Breakdown of academic impact, for papers by Daigo Ochiai
Rankless by CCL
2026